Literature DB >> 17427190

Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).

Petra Nowotny1, Xavier Simcock, Sarah Bertelsen, Anthony L Hinrichs, John S K Kauwe, Kevin Mayo, Scott Smemo, John C Morris, Alison Goate.   

Abstract

Linkage studies have suggested a susceptibility locus for late-onset Alzheimer's disease (LOAD) on chromosome 21. A functional candidate gene in this region is the beta-amyloid precursor protein (APP) gene. Previously, coding mutations in APP have been associated with early onset Alzheimer's Disease (EOAD). Three copies of APP are associated with AD pathology in Down's syndrome and in EOAD, suggesting that overexpression of APP may be a risk factor for LOAD. Although APP is a strong functional and positional candidate, to date there has been no thorough investigation using a dense map of SNPs across the APP gene. In order to investigate the role of common variation in the APP gene in the risk of LOAD, we genotyped 44 SNPs, spanning 300 kb spanning the entire gene, in a large case-control series of 738 AD cases and 657 healthy controls. The SNPs showed no association in genotypic or allelic tests, even after stratification for presence or absence of the APOE 4 allele. Haplotype analysis also failed to reveal significant association with any common haplotypes. These results suggest that common variation in the APP gene is not a significant risk factor for LOAD. However, we cannot rule out the possibility that multiple rare variants that increase APP expression or Abeta production might influence the risk for LOAD. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17427190     DOI: 10.1002/ajmg.b.30485

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

1.  Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease.

Authors:  Ana Miar; Victoria Alvarez; Ana I Corao; Marta Díaz; Belén Alonso; Carmen Martínez; María T Calatayud; Manuel Menéndez; Germán Morís; Eliecer Coto
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

2.  Genetic susceptibility for Alzheimer disease neuritic plaque pathology.

Authors:  Joshua M Shulman; Kewei Chen; Brendan T Keenan; Lori B Chibnik; Adam Fleisher; Pradeep Thiyyagura; Auttawut Roontiva; Cristin McCabe; Nikolaos A Patsopoulos; Jason J Corneveaux; Lei Yu; Matthew J Huentelman; Denis A Evans; Julie A Schneider; Eric M Reiman; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

3.  Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.

Authors:  Gaël Nicolas; David Wallon; Claudia Goupil; Anne-Claire Richard; Cyril Pottier; Véronique Dorval; Mariana Sarov-Rivière; Florence Riant; Dominique Hervé; Philippe Amouyel; Maelenn Guerchet; Bebene Ndamba-Bandzouzi; Pascal Mbelesso; Jean-François Dartigues; Jean-Charles Lambert; Pierre-Marie Preux; Thierry Frebourg; Dominique Campion; Didier Hannequin; Elisabeth Tournier-Lasserve; Sébastien S Hébert; Anne Rovelet-Lecrux
Journal:  Eur J Hum Genet       Date:  2015-04-01       Impact factor: 4.246

4.  Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.

Authors:  Shubhabrata Mukherjee; Joshua C Russell; Daniel T Carr; Jeremy D Burgess; Mariet Allen; Daniel J Serie; Kevin L Boehme; John S K Kauwe; Adam C Naj; David W Fardo; Dennis W Dickson; Thomas J Montine; Nilufer Ertekin-Taner; Matt R Kaeberlein; Paul K Crane
Journal:  Alzheimers Dement       Date:  2017-02-24       Impact factor: 21.566

5.  Role of common and rare APP DNA sequence variants in Alzheimer disease.

Authors:  B V Hooli; G Mohapatra; M Mattheisen; A R Parrado; J T Roehr; Y Shen; J F Gusella; R Moir; A J Saunders; C Lange; R E Tanzi; L Bertram
Journal:  Neurology       Date:  2012-04-04       Impact factor: 9.910

6.  APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.

Authors:  Terhi Peuralinna; Maarit Tanskanen; Mira Mäkelä; Tuomo Polvikoski; Anders Paetau; Hannu Kalimo; Raimo Sulkava; John Hardy; Shiao-Lin Lai; Sampath Arepalli; Dena Hernandez; Bryan J Traynor; Andrew Singleton; Pentti J Tienari; Liisa Myllykangas
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.

Authors:  Amy Gerrish; Giancarlo Russo; Alexander Richards; Valentina Moskvina; Dobril Ivanov; Denise Harold; Rebecca Sims; Richard Abraham; Paul Hollingworth; Jade Chapman; Marian Hamshere; Jaspreet Singh Pahwa; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Janet A Johnston; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Heike Kölsch; Reinhard Heun; Britta Schürmann; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Gail Davies; Sarah E Harris; John M Starr; Ian J Deary; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Lesley Jones; Peter A Holmans; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.